!

COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Baylor College of Medicine

Dapagliflozin in Respiratory Failure in Patients With COVID-19 (DARE-19)

Description

Content

In this study, we are enrolling patients who present to our Emergency Department with mild-moderate COVID-19. The goal is to evaluate the efficacy and safety of Dapagliflozin in those patients. This is a phase III, international, randomized, double-blind, placebo-controlled study.

Learn more information.

Contact

EM Research Team

Phone 1: 713–873–9818

IRB: H-47759

Status:

Active

Created:

Back to topback-to-top